Rosemont Pharmaceuticals announces US availability of ATMEKSI® (methocarbamol) Oral Suspension for acute MSK conditions
Rosemont Pharmaceuticals announces U.S. availability of ATMEKSI® (methocarbamol) Oral Suspension, a muscle relaxant treating acute musculoskeletal conditions GREENVILLE, SC, UNITED STATES, February 20, 2026 /EINPresswire.com/ -- Rosemont …